MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1158/2767-9764.crc-23-0396

Медицинская библиотека · Cancer research communications · 2024

Drug-resilient Cancer Cell Phenotype Is Acquired via Polyploidization Associated with Early Stress Response Coupled to HIF2α Transcriptional Regulation.

Carroll Christopher, Manaprasertsak Auraya, Boffelli Castro Arthur, van den Bos Hilda, Spierings Diana C J, Wardenaar René, Bukkuri Anuraag, Engström Niklas, Baratchart Etienne, Yang Minjun, Biloglav Andrea, Cornwallis Charlie K, Johansson Bertil, Hagerling Catharina, Arsenian-Henriksson Marie, Paulsson Kajsa, Amend Sarah R, Mohlin Sofie, Foijer Floris, McIntyre Alan, Pienta Kenneth J, Hammarlund Emma U

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

UNLABELLED: Therapeutic resistance and recurrence remain core challenges in cancer therapy. How therapy resistance arises is currently not fully understood with tumors surviving via multiple alternative routes. Here, we demonstrate that a subset of cancer cells survives therapeutic stress by entering a transient state characterized by whole-genome doubling. At the onset of the polyploidization program, we identified an upregulation of key transcriptional regulators, including the early stress-response protein AP-1 and normoxic stabilization of HIF2α. We found altered chromatin accessibility, ablated expression of retinoblastoma protein (RB1), and enrichment of AP-1 motif accessibility. We demonstrate that AP-1 and HIF2α regulate a therapy resilient and survivor phenotype in cancer cells. Consistent with this, genetic or pharmacologic targeting of AP-1 and HIF2α reduced the number of surviving cells following chemotherapy treatment. The role of AP-1 and HIF2α in stress response by polyploidy suggests a novel avenue for tackling chemotherapy-induced resistance in cancer.

SIGNIFICANCE: In response to cisplatin treatment, some surviving cancer cells undergo whole-genome duplications without mitosis, which represents a mechanism of drug resistance. This study presents mechanistic data to implicate AP-1 and HIF2α signaling in the formation of this surviving cell phenotype. The results open a new avenue for targeting drug-resistant cells.

Для цитирования: Carroll Christopher, Manaprasertsak Auraya, Boffelli Castro Arthur, van den Bos Hilda, Spierings Diana C J, Wardenaar René, Bukkuri Anuraag, Engström Niklas, Baratchart Etienne, Yang Minjun, Biloglav Andrea, Cornwallis Charlie K, Johansson Bertil, Hagerling Catharina, Arsenian-Henriksson Marie, Paulsson Kajsa, Amend Sarah R, Mohlin Sofie, Foijer Floris, McIntyre Alan, Pienta Kenneth J, Hammarlund Emma U. Drug-resilient Cancer Cell Phenotype Is Acquired via Polyploidization Associated with Early Stress Response Coupled to HIF2α Transcriptional Regulation.. Cancer research communications. 2024. DOI: 10.1158/2767-9764.crc-23-0396.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.